Cost–effectiveness analysis of sofosbuvir, peginterferon and ribavirin in patients with chronic hepatitis C: Early treatment in the initial stage of fibrosis vs. delayed treatment in advanced fibrosis
2016 ◽
Vol 39
(7)
◽
pp. 449-457
2016 ◽
Vol 146
(2)
◽
pp. 61-64
◽
2015 ◽
Vol 18
(7)
◽
pp. 502-511
◽
2015 ◽
Vol 2015
◽
pp. 1-10
◽
2013 ◽
Vol 11
(1)
◽
pp. 25
◽